Xbrane Biopharma

Major Shareholding Notification • Mar 26, 2024

Issuer Xbrane Biopharma AB

Holder

Nordnet AB (publ)

Instrument

Instrument	Aktie SE0007789409
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification New share issue
Date	25/03/2024
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	80,730,876
Directly held voting rights	0
Indirectly held voting rights	80,730,876
Percentage
Directly held shares	5.27831 %
Directly held voting rights	0 %
Indirectly held voting rights	5.27831 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.27831 %	80,730,876
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	5.27831 %	80,730,876
Chain of controlling companies

	Voting rights % Voting rights Company
80,378,275 5.25525		Nordnet Pensionsförsäkring AB
352,601	0.02305	Nordnet Livsforsikring AS
Group total holdings
Voting rights		80,730,876

Percentage of voting rights 5.27831

Notes (other relevant informations according to law)

Flaggning beräknad på nytt antal aktier och röster (1 529 483 397) efter registrerad företrädes- och ersättningsemission.

Published

26/03/2024 15:15

Contact

Name Felix Mandoki Phone +46766110734 Email felix.mandoki@nordnet.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25